The PE Ratio as of December 2025 (TTM) for Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) is 56.78

According to Hangzhou Biotest Biotech Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 56.78. This represents a change of -42.24% compared to the average of 98.31 of the last 4 quarters.

Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) Historical PE Ratio (quarterly & annually)

How has 688767.SS PE Ratio performed in the past?

The mean historical PE Ratio of Hangzhou Biotest Biotech Co.,Ltd. over the last ten years is 200.07. The current 56.78 PE Ratio has changed 2.74% with respect to the historical average. Over the past ten years (40 quarters), 688767.SS's PE Ratio was at its highest in in the June 2025 quarter at 266.20. The PE Ratio was at its lowest in in the December 2022 quarter at -7.87.

Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Hangzhou Biotest Biotech Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) Average PE Ratio

How has 688767.SS PE Ratio performed in the past?

The current PE Ratio of Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) PE Ratio vs. Peers

How is 688767.SS’s PE Ratio compared to its peers?

Hangzhou Biotest Biotech Co.,Ltd.’s PE Ratio is greater than Novogene Co., Ltd. (31.63), greater than Xiangxue Pharmaceutical Co.,Ltd. (-6.16), greater than Jiangsu Bioperfectus Technologies Co., Ltd. (-219.59), greater than Assure Tech (Hangzhou) Co., Ltd. (41.19), greater than Jiangsu Aidea Pharmaceutical Co., Ltd. (-73.09), greater than Jiangxi Fushine Pharmaceutical Co., Ltd. (-29.03), greater than Hefei Lifeon Pharmaceutical Co., Ltd. (32.06), greater than Zhejiang Yatai Pharmaceutical Co., Ltd. (40.68), greater than Wuhan Keqian Biology Co.,Ltd (15.70), greater than Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (53.72),

Build a custom stock screener for Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hangzhou Biotest Biotech Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hangzhou Biotest Biotech Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.